Polyarteritis nodosa: A contemporary overview

Autoimmunity Reviews

Volumn 15, Issue 6, 2016, Pages 564-570

  De Virgilio, Armando ^a,b   Greco, Antonio ^a   Magliulo, Giuseppe ^a   Gallo, Andrea ^a   Ruoppolo, Giovanni ^a   Conte, Michela ^a   Martellucci, Salvatore ^a   de Vincentiis, Marco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Autoimmunity; Cyclophosphamide; Hepatitis B; Immunology; Polyarteritis nodosa; Vasculitis

Indexed keywords

CYCLOPHOSPHAMIDE; GLUCOCORTICOID; NONSTEROID ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT;

CLINICAL FEATURE; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; HEPATITIS B; HISTOPATHOLOGY; HUMAN; IDIOPATHIC DISEASE; NONHUMAN; PATHOGENESIS; POLYARTERITIS NODOSA; PROGNOSIS; REVIEW; AUTOIMMUNE DISEASES; PATHOLOGY; TREATMENT OUTCOME;

ANTIVIRAL AGENTS; AUTOIMMUNE DISEASES; CYCLOPHOSPHAMIDE; HUMANS; POLYARTERITIS NODOSA; TREATMENT OUTCOME;

EID: 84959141189     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2016.02.015     Document Type: Review

References (77)

1. Jennette J.C., Falk R.J., Bacon P.A., Basu N., Cid M.C., Ferrario F., et al. 2012 Revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013, 65:1-11.
2. Lie J.T. Systemic and isolated vasculitis. A rational approach to classification and pathologic diagnosis. Pathol Annu 1989, 24:25-114.
3. Tesar V., Kazderova M., Klavackova L. Rokitansky and his first description of polyarteritis nodosa. J Nephrol 2004, 17:172-174.
4. Matteson E.L., Kluge F.J. Think clearly, be sincere, act calmly: Adolf Kussmaul (February 22, 1822 - May 28, 1902) and his relevance to medicine in the 21st century. Curr Opin Rheumatol 2003, 15:29-34.
5. Anderson W.A.D., Kissane J.M. Pathology, vol. 1. 7th ed 1977, St. Louis, CV Mosby.
6. Robbins S.L. Pathologic basis of disease 1984, W.B. Saunders Company, Philadelphia.
7. Lindberg K. Ein beitrag zur kenntnis der periarteritis nodosa. Acta Med Scand 1931, 76:183.
8. Trepo C., Thivolet J. Hepatitis associated antigen and periarteritis nodosa (PAN). Vox Sang 1970, 19:410-411.
9. Hernandez-Rodriguez J., Alba M.A., Prieto-Gonzalez S., Cid M.C. Diagnosis and classification of polyarteritis nodosa. J Autoimmun 2014, 48-49:84-89.
10. González-Gay M.A., García-Porrúa C., Guerrero J., Rodríguez-Ledo P., Llorca J. The epidemiology of the primary systemic vasculitides in Northwest Spain: implications of the Chapel Hill consensus conference definitions. Arthritis Rheum 2003, 49:388-393.
11. Mohammad A.J., Jacobsson L.T., Mahr A.D., Sturfelt G., Segelmark M. Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and churg Strauss syndrome within a defined population in Southern Sweden. Rheumatology (Oxford) 2007, 46:1329-1337.
12. Guillevin L. Polyarteritis nodosa and microscopic polyangiitis. Vasculitis 2002, 300-320. Oxford University Press, New York. G.V. Ball, S.L. Bridges (Eds.).
13. Patel N., Patel N., Khan T., Patel N., Espinoza L.R. HIV infection and clinical spectrum of associated vasculitides. Curr Rheumatol Rep 2011, 13:506-512.
14. Mahr A., Guillevin L., Poissonnet M., Aymé S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 2004, 51:92-99.
15. Filer A.D., Gardner-Medwin J.M., Thambyrajah J., Raza K., Carruthers D.M., Stevens R.J., et al. Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa. Ann Rheum Dis 2003, 62:162-167.
16. Chanseaud Y., Pena-Lefebvre P.G., Guilpain P., Mahr A., Tamby M.C., Uzan M., et al. IgM and IgG autoantibodies from microscopic polyangiitis patients but not those with other small- and medium-sized vessel vasculitides recognize multiple endothelial cell antigens. Clin Immunol 2003, 109:165-178.
17. Freire Ade L., Bertolo M.B., de Pinho A.J., Samara A.M., Fernandes S.R. Increased serum levels of interleukin-8 in polyarteritis nodosa and Behcet's disease. Clin Rheumatol 2004, 23:203-205.
18. Coll-Vinent B., Grau J.M., Lopez-Soto A., Oristrell J., Font C., Bosch X., et al. Circulating soluble adhesion molecules in patients with classical polyarteritis nodosa. Br J Rheumatol 1997, 36:1178-1183.
19. Soto O., Conn D.L. Polyarteritis nodosa and microscopic polyangiitis. Rheumatology 2003, 1611-1621. Mosby, Edingurgh. M.C. Hochberg, A.J. Silman, J.S. Smolen, M.E. Weimblatt, M.H. Weisman (Eds.).
20. Trepo C., Guillevin L. Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis. J Autoimmun 2001, 16:269-274.
21. Stone J.H. Polyarteritis nodosa. JAMA 2002, 288:1632-1639.
22. Agard C., Mouthon L., Mahr A., Guillevin L. Microscopic polyangiitis and polyarteritis nodosa: how and when do they start?. Arthritis Rheum 2003, 49:709-715.
23. Ball G.V., Bridges S.L. Polyarteritis nodosa. Arthritis and allied conditions. A textbook in rheumatology 2005, 1767-1775. Lippincott Williams & Wilkins, Philadelphia. W.J. Koopman, L.W. Moreland (Eds.).
24. Plumley S.G., Rubio R., Alasfar S., Jasin H.E. Polyarteritis nodosa presenting as polymyositis. Semin Arthritis Rheum 2002, 31:377-383.
25. Pagnoux C., Seror R., Henegar C., Mahr A., Cohen P., Le Guern V., et al. French Vasculitis Study Group. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum 2010, 62:616-626.
26. Selga D., Mohammad A., Sturfelt G., Segelmark M. Polyarteritis nodosa when applying the Chapel Hill nomenclature e a descriptive study on ten patients. Rheumatology (Oxford) 2006, 45:1276-1281.
27. Lhote F., Cohen P., Guillevin L. Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome. Lupus 1998, 7:238-258.
28. Pagnoux C., Mahr A., Cohen P., Guillevin L. Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Medicine (Baltimore) 2005, 84:115-128.
29. Adkins W.Y., Ward P.H. Temporal bone showing polyarteritis nodosa, otosclerosis, and occult neuroma. Laryngoscope 1986, 96:645-652.
30. Wolf M., Kronenberg J., Engelberg S., Leventon G. Rapidly progressive hearing loss as a symptom of polyarteritis nodosa. Am J Otolaryngol 1987, 8:105-108.
31. Bomholt A., Knudsen J.B., Fermin H., Tommerup B., Gormsen J. Profound sensorineural hearing loss in polyarteritis nodosa. An atypical case of Cogan's syndrome. Arch Otorhinolaryngol 1982, 236:53-58.
32. Rowe-Jones J.M., Macallan D.C., Sorooshian M. Polyarteritis nodosa presenting as bilateral sudden onset cochleo-vestibular failure in a young woman. J Laryngol Otol 1990, 104:562-564.
33. Lake-Bakaar G. Polyarteritis nodosa presenting with bilateral nerve deafness. J R Soc Med 1978, 71:144-147.
34. Tsunoda K., Akaogi J., Ohya N., Murofushi T. Sensorineural hearing loss as the initial manifestation of polyarteritis nodosa. J Laryngol Owl 2001, 115:311-312.
35. Peitersen E., Carlsen B.H. Hearing impairment as the initial sign of polyarteritis nodosa. Acta Otolaryngol (Stockh) 1966, 61:189-195.
36. Ishiguro N., Kawashima M. Cutaneous polyarteritis nodosa: a report of 16 cases with clinical and histopathological analysis and a review of the published work. J Dermatol 2010, 37:85-93.
37. Morgan A.J., Schwartz R.A. Cutaneous polyarteritis nodosa: a comprehensive review. Int J Dermatol 2010, 49:750-756.
38. Gocke D.J., Hsu K., Morgan C., Bombar, Dieri S., Lockshtn M., et al. Association between polyarteritis and Australia antigen. Lancet 1970, 2:149-153.
39. Saadoun D., Terrier B., Semoun O., Sene D., Majsonobe T., Musse T.L., et al. Hepatitis C virus-associated polyarteritis nodosa. Arthritis Care Res (Hoboken) 2011, 63:427-435.
40. Porter B.F., Frost P., Hubbard G.B. Polyarteritis nodosa in a cynomolgus macaque (Macaca fascicularis). Vet Pathol 2003, 40:570-573.
41. Jennette J.C. Implications for pathogenesis of patterns of injury in small- and medium-sized-vessel vasculitis. Cleve Clin J Med 2002, 69:33-38.
42. Cid M.C., Grau J.M., Casademont J., Campo E., Coll-Vinent B., López-Soto A., et al. Immunohistochemical characterization of inflammatory cells and immunologic activation markers in muscle and nerve biopsy specimens from patients with systemic polyarteritis nodosa. Arthritis Rheum 1994, 37:1055-1061.
43. Coll-Vinent B., Cebrián M., Cid M.C., Font C., Esparza J., Juan M., et al. Dynamic pattern of endothelial cell adhesion molecule expression in muscle and perineural vessels from patients with classic polyarteritis nodosa. Arthritis Rheum 1998, 41:435-444.
44. Jenkins H.A., Pollak A.M., Fisch U. Polyarteritis nodosa as a cause of sudden deafness. A human temporal bone study. Am J Otolaryngol 1981, 2:99-107.
45. Yoon T.H., Paparella M.M., Schachern P.A. Systemic vasculitis: a temporal bone histopathologic study. Laryngoscope 1989, 99:600-609.
46. Kimura R., Perlman H.B. Extensive venous obstruction of the labyrinth. A: cochlear changes. Ann Otol Rhinol Laryngol 1956, 65:332-351.
47. Blatt I.M., Lawrence M. Otologic manifestations of fatal granulomatosis of respiratory tract. Arch Otolaryngol 1961, 73:37-41.
48. Booth J.B. Sudden and fluctuant sensorineural hearing loss. Scott-Brown's Otolaryngology 1997, 1-82. Butterworth-Heinemann, Oxford. 6th ed. M. Gleeson (Ed.).
49. Gussen P. Polyarteritis nodosa and deafness. A human temporal bone study. Arch Otorhinolaryngol 1977, 217:263-271.
50. Paranisi E., Vincenti V., Bacciu A., Guida M., Berghenti T., Barbot A., et al. Cochlear implantation and Cogan syndrome. Otol Neurotol 2003, 24:601-604.
51. Minet M., Deggouj N., Gersdorff M. Cochlear implantation in patients with Cogan's syndrome: a review of four cases. Eur Arch Otorhinolaryngol 1997, 254:459-462.
52. Greco A., Gallo A., Fusconi M., Magliulo G., Turchetta R., Marinelli C., et al. Cogan's syndrome: an autoimmune inner ear disease. Autoimmun Rev 2013, 12:396-400.
53. Watts R., Lane S., Hanslik T., Hauser T., Hellmich B., Koldingsnes W., et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 2007, 66:222-227.
54. Albert D.A., Rimon D., Silverstein M.D. The diagnosis of polyarteritis nodosa. I. A literature-based decision analysis approach. Arthritis Rheum 1988, 31:1117-1127.
55. Bleeker-Rovers C.P., Bredie S.J., van der Meer J.W., Corstens F.H., Oyen W.J. Fluorine 18 fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis. Am J Med 2004, 116:50-53.
56. Greco A., Rizzo M.I., De Virgilio A., Gallo A., Fusconi M., Ruoppolo G., et al. Churg-Strauss syndrome. Autoimmun Rev 2015, 14:341-348.
57. Guillevin L., Lhote F., Amouroux J., Gherardi R., Callard P., Casassus P. Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: indications for the classification of vasculitides of the polyarteritis Nodosa Group. Br J Rheumatol 1996, 35:958-964.
58. Greco A., De Virgilio A., Rizzo M.I., Gallo A., Magliulo G., Fusconi M., et al. Microscopic polyangiitis: advances in diagnostic and therapeutic approaches. Autoimmun Rev 2015, 14:837-844.
59. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children (in Japanese). Arerugi 1967, 16:178-222.
60. Greco A., De Virgilio A., Rizzo M.I., Tombolini M., Gallo A., Fusconi M., et al. Kawasaki disease: an evolving paradigm. Autoimmun Rev 2015, 14:703-709.
61. Langford C.A. Treatment of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: where do we stand?. Arthritis Rheum 2001, 44:508-512.
62. Guillevin L. Treatment of classic polyarteritis nodosa in 1999. Nephrol Dial Transplant 1999, 14:2077-2079.
63. Guillevin L., Cohen P., Mahr A., Arène J.P., Mouthon L., Puéchal X., et al. Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients. Arthritis Rheum 2003, 49:93-100.
64. Guillevin L., Lhote F., Gayraud M., Cohen P., Jarrousse B., Lortholary O., et al. prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 1996, 75:17-28.
65. Balow J.E. Renal vasculitis. Kidney Int 1985, 27:954-964.
66. Frohnert P.P., Sheps S.G. Long-term follow-up study of periarteritis nodosa. Am J Med 1967, 43:8-14.
67. Guillevin L., Pagnoux C., Seror R., Mahr A., Mouthon L., Le Toumelin P., et al. The five-factor score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine 2011, 90:19-27.
68. Bourgarit A., Le Toumelin P., Pagnoux C., Cohen P., Mahr A., Le Guern V., et al. Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients. Medicine 2005, 84:323-330.
69. Ribi C., Cohen P., Pagnoux C., Mahr A., Arène J.P., Puéchal X., et al. French Vasculitis Study Group. Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: a prospective randomized study of one hundred twenty-four patients. Arthritis Rheum 2010, 62:1186-1197.
70. Mukhtyar C., Guillevin L., Cid M.C., Dasgupta B., de Groot K., Gross W., et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 2009, 68:310-317.
71. Gayraud M., Guillevin L., Cohen P., Lhote F., Cacoub P., Deblois P., et al. Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for vasculitides. Br J Rheumatol 1997, 36:1290-1297.
72. Keystone E.C. The utility of tumour necrosis factor blockade in orphan diseases. Ann Rheum Dis 2004, 63:79-83.
73. Guillevin L., Mouthon L. Tumor necrosis factor-alpha blockade and the risk of vasculitis. J Rheumatol 2004, 31:1885-1887.
74. Farrell G.C., Teoh N.C. Management of chronic hepatitis B virus infection: a new era of disease control. Intern Med J 2006, 36:100-113.
75. Guillevin L., Lhote F., Leon A., Fauvelle F., Vivitski L., Trepo C. Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients. J Rheumatol 1993, 20:289-298.
76. Guillevin L., Lhote F., Sauvaget F., Deblois P., Rossi F., Levallois D., et al. Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges. Ann Rheum Dis 1994, 53:334-337.
77. Guillevin L., Mahr A., Cohen P., Larroche C., Queyrel V., Loustaud-Ratti V., et al. Short-term corticost,eroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa. Arthritis Rheum 2004, 51:482-487.